Pneumococcal conjugate vaccine implementation in middle-income countries

BACKGROUND: Since 2000, the widespread adoption of pneumococcal conjugate vaccines (PCVs) has had a major impact in the prevention of pneumonia. Limited access to international financial support means some middle-income countries (MICs) are trailing in the widespread use of PCVs. We review the statu...

Descripción completa

Detalles Bibliográficos
Autores principales: Tricarico, Serena, McNeil, Hannah C., Cleary, David W., Head, Michael G., Lim, Victor, Yap, Ivan Kok Seng, Wie, Chong Chun, Tan, Cheng Siang, Norazmi, Mohd Nor, Aziah, Ismail, Cheah, Eddy Seong Guan, Faust, Saul N., Jefferies, Johanna M.C., Roderick, Paul J., Moore, Michael, Yuen, Ho Ming, Newell, Marie-Louise, McGrath, Nuala, Doncaster, C. Patrick, Kraaijeveld, Alex R., Webb, Jeremy S., Clarke, Stuart C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471880/
https://www.ncbi.nlm.nih.gov/pubmed/28702308
http://dx.doi.org/10.1186/s41479-017-0030-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471880/
https://www.ncbi.nlm.nih.gov/pubmed/28702308
http://dx.doi.org/10.1186/s41479-017-0030-5

Ejemplares similares